P&T Perspectives

Real P&T Professionals. Real Market Research.

Gain Insights from Real P&T Professionals

What Our Clients Are Saying

How We Can Help

MMIT’s industry-leading P&T panel is composed of pharmacy decision-makers from health plans, pharmacy benefit managers (PBMs), providers, and integrated delivery systems (IDNs). With 100% of panelists actively participating in P&T committees or directly controlling pharmaceutical access within their organizations, MMIT delivers unparalleled visibility into payer decision-making, formulary access, and market access strategy.

How can P&T Perspectives help my team predict how payers will evaluate our drug?

P&T Perspectives enables your team to forecast how real P&T committee members will evaluate your drug by simulating an authentic review that reveals competitive positioning and payer decision‑making dynamics.

How can P&T Perspectives help optimize pricing and formulary placement strategy?

P&T Perspectives provides direct insight into how pricing and clinical value influence formulary placement by showing how pharmacy and medical decision‑makers assess financial impact and therapeutic differentiation.

How can P&T Perspectives help identify potential coverage restrictions before launch?

P&T Perspectives helps you anticipate likely coverage restrictions—such as prior authorization, step therapy, and contracting requirements—by identifying the controls P&T stakeholders would apply during a simulated committee review.

Key Insights From MMIT

Improving Access with Market Research Insights

In this ebook, see how nine different manufacturers have partnered with MMIT on qualitative and quantitative custom market research.

ACCESS THE RESOURCE
ACCESS THE RESOURCE

Strategies for Early Market Access Planning

This webinar explores how pharmaceutical companies are moving market access planning earlier into phases 1–3 to improve launch readiness, payer alignment, and long-term commercial performance. Speakers discuss how growing competition, pricing pressure, and regulatory changes are increasing the need for early, data-driven access strategy built on analog analysis, payer research, and integrated real-world data. The session also highlights how these insights help manufacturers refine value propositions, shape clinical development decisions, anticipate payer behavior, and strengthen commercialization strategy before launch.

What you’ll learn:

  • How historic analogs can help your team decide whether to pursue or license a product.
  • When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition.
  • What kind of data helps you anticipate (and circumvent) launch disadvantages.
ACCESS THE RESOURCE
ACCESS THE RESOURCE

Preparing for Launch with P&T Perspectives

Learn how a P&T review helped one pharma company understand how its product would be assessed, leading to a new focus on gathering real-world evidence.

ACCESS THE RESOURCE
ACCESS THE RESOURCE
Stay In Touch

Be the first to know about new arrivals and promotions

Upcoming Webinar: Achieving Your Uptake Goals